To round off 2022, Rebekah Jordan reflects on EPM's published stories this past year, from post-pandemic advancements to sustainability awards, along with pharma's drive towards digital transformation.
Post-pandemic advances
Two years after the pandemic and the pharma industry is not short in its advancements. August 2022 saw the update of Moderna's original Covid-19 vaccine to a bivalent booster; targeting both the Omicron variant and the original 2020 virus. After receiving MHRA approval, the dual variant boosters were rolled out in the UK as Autumn booster vaccines.